Search

Contributor:

Carl D. Regillo, MD, FACS

Angiogenesis 2021: Wet AMD

Matching Patients to Therapy in Wet AMD: How New Technology May Alleviate Treatment Burden

COVID-19: Can Clinical Trials Proceed?

Angiogenesis 2021: Wet AMD

COVID-19: Can Clinical Trials Proceed?

John Kitchens, MD; Namrata Saroj, OD; Jeffrey Heier, MD; Carl Regillo, MD; and Charles Wykoff, MD, PhD

Surgical options for treating AMD: Clinical Implications and Impact

Reconsidering treatment endpoints in real-world clinical practice: is achieving a favorable retreatment interval a goal of therapy?

Real-world impact of patients lost to follow-up: factors that drive nonadherence and strategies for encouraging better follow-up from patients

Back to Practice: Telemedicine & Combating Patient Misinformation

Case Presentation: Carl Regillo, MD

Case Presentation: Carl Regillo, MD

Vitreomacular Traction

Vitreomacular Traction

Carl Regillo, MD

Ocriplasmin for the Treatment of Symptomatic Vitreomacular Adhesion

Ocriplasmin for the Treatment of Symptomatic Vitreomacular Adhesion

Carl Regillo, MD

Chandelier Light

Chandelier Light

Prepping and Draping

Prepping and Draping

Perfluorocarbon Liquids: Pearls and Pitfalls

Perfluorocarbon Liquids: Pearls and Pitfalls

Carl Regillo, MD, Timothy Murray, MD, MBA

COVID-19: Can Clinical Trials Proceed?

COVID-19: Can Clinical Trials Proceed?

Jeffrey Heier, MD, Carl D. Regillo, MD, FACS, Charles C. Wykoff, MD, PhD, FACS, John Kitchens, MD, Namrata Saroj, OD

Optimizing Visual Outcomes in Wet AMD

Optimizing Visual Outcomes in Wet AMD

Carl D. Regillo, MD, FACS

Scleral Depressed Vitreous Shaving

Scleral Depressed Vitreous Shaving

Micro Incision Vitrectomy Systems II

Micro Incision Vitrectomy Systems II

Micro Incision Vitrectomy Systems I

Micro Incision Vitrectomy Systems I

Posterior Retinal Break

Posterior Retinal Break

Carl Regillo, MD